PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis. - Wikidata - wikimedia - TriplyDB

PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.

PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.

http://www.wikidata.org/entity/Q35936041

about

Role of the PD-1 pathway in the immune response Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure.Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma.Neopterin and beta-2 microglobulin relations to immunity and inflammatory status in nonischemic dilated cardiomyopathy patients Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes.Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated immunosenescence in CMV-seropositive patients Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153.Monoclonal antibodies specific to human Δ42PD1: A novel immunoregulator potentially involved in HIV-1 and tumor pathogenesis.Interferon-γ-mediated allograft rejection exacerbates cardiovascular disease of hyperlipidemic murine transplant recipients.Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils.The heart of the matter: protection of the myocardium from T cells Synthetic RORγt Agonists Enhance Protective Immunity.Fulminant Myocarditis with Combination Immune Checkpoint Blockade.A Century of Radiation Therapy and Adaptive Immunity Treating atherosclerosis with regulatory T cells.A perspective on the impact of radiation therapy on the immune rheostat.T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases.Improved survival after induction of sepsis by cecal slurry in PD-1 knockout murine neonates.Cardiovascular Toxicities Associated with Cancer Immunotherapies.[Lymphocytic myocarditis in a patient with metastatic clear cell renal cell carcinoma treated with Nivolumab].Cardiac Autoimmunity: Myocarditis.Immunological Properties of Murine Parthenogenetic Stem Cell-Derived Cardiomyocytes and Engineered Heart Muscle Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy Two sides to every proinflammatory coin: new insights into the role of dendritic cells in the regulation of T-cell driven autoimmune myocarditis Smoldering myocarditis following immune checkpoint blockade.Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report.Program Cell Death Receptor-1-Mediated Invariant Natural Killer T-Cell Control of Peritoneal Macrophage Modulates Survival in Neonatal Sepsis.Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer.Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects.The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC.Immune checkpoint inhibitor-related myocarditis.Fibrinogen-like protein-2 causes deterioration in cardiac function in experimental autoimmune myocarditis rats through regulation of programmed death-1 and inflammatory cytokines.PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease.Fatal myocarditis and rhabdomyolysis induced by nivolumab during the treatment of type B3 thymoma.Suspected autoimmune myocarditis and cardiac conduction abnormalities with nivolumab therapy for non-small cell lung cancer.Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients.Lung cancer as a cardiotoxic state: a review.Cardiotoxicity of immune checkpoint inhibitors.

P2860

Q26828748-9121AB64-88C2-43AB-AE4F-20A800124A42 Q27340146-F3FA6F3D-4FA9-4BC7-BD5A-89498A4C256A Q30641952-EF907F93-C110-446C-9A4E-72F02C1974F0 Q34118314-DEC859A2-238C-4CA5-A38E-7AB3BAA011C0 Q34173755-74C3113C-5424-4F5F-ACC1-8E026B6EBFBF Q34790920-7AA898F7-825D-4FD2-B930-6DAAA2133925 Q35611631-5C90B14E-4C00-40F7-BAAA-4E0E7E5776E1 Q36211501-556F936F-0A4A-4994-8709-8B5332F25224 Q36259538-13462E78-3405-43FF-BE2E-ED188B4FD0D2 Q37095348-0BE475C8-AFA6-4CC9-988D-994746A44B46 Q37176323-A2BD75FF-B61F-4EC5-8D93-F8A60F7EE713 Q37198750-DE43A393-7790-4060-9B4F-93EA48F37744 Q37526761-B5899E29-DEEB-45DD-ADDF-381FB6AEAF0E Q37595462-594A4205-9233-4EEA-8427-C5409D49C501 Q37747153-11917531-07C5-479F-821F-443E35968BE6 Q38270134-AD22C2A4-DD23-4C6D-AF8E-F6C9F2ADF4DF Q38679488-128766F0-EB28-441C-8A50-8A9ED9B6E334 Q38826175-27DD6038-12A8-4228-B321-285222476871 Q39066825-6981C800-521A-4404-9ECF-A7E4A71647AB Q39144916-019B9C9D-D79F-45A3-80ED-01F0CF29DA0D Q40078647-AC4EB922-10DE-4949-A124-00D7CCC2668C Q40138726-F8A82959-481A-4937-90DF-2E854EC0E9B7 Q41417860-3AC6A4DE-087E-414B-83DC-787478D2C144 Q42354162-CAE32644-D369-41C6-A04E-56895C7CFCA5 Q42649294-F2514D56-2414-4FD9-AF9D-77AF47ECD0E3 Q47105402-D68650F6-161B-4698-81BE-14671AF129C6 Q47148480-63948C15-B158-448E-8721-588518988418 Q47160878-15833A7B-6C41-4563-B25E-3E79C119F857 Q47162183-92FA924D-41FB-4251-BA7D-E8EF258A0BC7 Q47224948-F5262677-1472-4D9E-88CB-6E4CFBB23C07 Q47239900-88064E13-07BD-4752-B4BD-FCABBA63D3F0 Q47553695-B25BFE57-BED0-4E84-993B-9A4CAF99FA24 Q47633085-74291B3D-54A5-4115-B7F7-5A29850EA558 Q47823401-E4E4726C-1FCB-4B2E-884C-6D6390759A5D Q48165202-52204E35-896B-4EFC-911B-CA84AF5AEE49 Q48324118-34663A7B-34CF-45C7-B3C1-4AEC1E96E396 Q51627654-682D37A7-8D71-452F-8F55-5BC8FEE86A09 Q52641866-B46854DF-9CC4-4808-BAC9-2559438E349E Q53117997-DBA5F0DE-FDAC-437E-A366-5572A731C4C3 Q55438414-7B0F5841-754F-4D28-B32D-069F651EC832

P2860

PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.

http://www.wikidata.org/entity/Q35936041

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.

@ast

PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.

@en

type

label

PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.

@ast

PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.

@en

prefLabel

PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.

@ast

PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.

@en

P1433

Q35936041-1A4C2D90-0E59-4754-9F19-73DB89861A46

P1476

Q35936041-7DE2627F-EAB7-46DE-8130-20F059F85972

P2093

Q35936041-7D60F29D-5437-4DDF-BEDD-96671D679C03

Q35936041-9D6CCB51-0037-4925-8CBC-5295B1ADDA6E

Q35936041-B777E2E4-7431-4777-B7A4-D0722812ED96

Q35936041-BADA85E9-E6FC-409F-A08E-4DCF2E8D032A

Q35936041-CA2227D8-F0DB-4757-81BF-6555E4E278C9

P2860

Q35936041-086DF698-940F-4A97-B7B1-E55E3F91D445

Q35936041-118255FD-0143-4039-9DEF-DACCDACDFAF5

Q35936041-1ED5EFEE-23B8-4590-9AFA-BB844FC92AE8

Q35936041-1F164D77-F982-4448-9EE7-18A7DD895D69

Q35936041-2845967B-30F4-4761-81CD-6C3DF20A2F4A

Q35936041-29DA49D3-AB74-468C-8BC7-A061B25FA444

Q35936041-2F603D58-55DF-40B5-A294-F72BE0D89010

Q35936041-38FF2A10-F69E-459E-8C06-0734A05A582B

Q35936041-4187410E-D82D-47BE-B1E9-00FD64EEC0DA

Q35936041-47141EE7-5665-4EBE-9E99-16A090DDFF79

P304

Q35936041-58F02D1C-49B8-413B-8410-E94FC613B360

P31

Q35936041-A7DE8A8C-0450-46F1-B345-C33CD154A1AC

P356

Q35936041-3104A210-3684-450C-8CF8-6F05381DA4B0

P407

Q35936041-C6CEE87F-D357-4F83-A70C-044C286EC958

P433

Q35936041-5B9C83B3-89DE-4CB8-98A6-4DE1F9E3155A

P478

Q35936041-2D3AC899-B926-4E64-A371-C7E8928D3DE5

P577

Q35936041-398854B8-89BC-428A-AD11-AE2F277A7AB9

P5875

Q35936041-36A064CA-F45E-40BE-B4EE-6E20544CE1FD

P698

Q35936041-BCD9FBA2-C4A4-4FE3-A39A-376D34F58FC1

P932

Q35936041-A0333ECF-3B4E-4C11-B636-EF539C547ADB

P356

JIMMUNOL.1200389

P1433

Journal of Immunology

P1476

PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.

@en

P2093

Andrew H Lichtman

http://www.w3.org/2001/XMLSchema#string

Arlene H Sharpe

http://www.w3.org/2001/XMLSchema#string

De-xiu Bu

http://www.w3.org/2001/XMLSchema#string

Margarite L Tarrio

http://www.w3.org/2001/XMLSchema#string

Nir Grabie

http://www.w3.org/2001/XMLSchema#string

P2860

The PD-1 pathway in tolerance and autoimmunity

PD-1 and its ligands in tolerance and immunity

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

T cell receptor antagonist peptides induce positive selection

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates

Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion

PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells

Cutting edge: CTLA-4--B7 interaction suppresses Th17 cell differentiation

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity.

Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice.

P304

4876-4884

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1200389

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

188

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223972718

http://www.w3.org/2001/XMLSchema#string

P698

22491251

http://www.w3.org/2001/XMLSchema#string

P932

3345066

http://www.w3.org/2001/XMLSchema#string